BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11123422)

  • 1. Allelic loss of 14q and 22q, NF2 mutation, and genetic instability occur independently of c-kit mutation in gastrointestinal stromal tumor.
    Fukasawa T; Chong JM; Sakurai S; Koshiishi N; Ikeno R; Tanaka A; Matsumoto Y; Hayashi Y; Koike M; Fukayama M
    Jpn J Cancer Res; 2000 Dec; 91(12):1241-9. PubMed ID: 11123422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofibromatosis type 1-related gastrointestinal stromal tumors: a special reference to loss of heterozygosity at 14q and 22q.
    Yamamoto H; Tobo T; Nakamori M; Imamura M; Kojima A; Oda Y; Nakamura N; Takahira T; Yao T; Tsuneyoshi M
    J Cancer Res Clin Oncol; 2009 Jun; 135(6):791-8. PubMed ID: 19020900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 22q alterations and expression of the NF2 gene product, merlin, in gastrointestinal stromal tumors.
    Pylkkänen L; Sarlomo-Rikala M; Wessman M; Hämäläinen E; Sainio M; Husgafvel-Pursiainen K; Carpén O
    Hum Pathol; 2003 Sep; 34(9):872-9. PubMed ID: 14562282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
    Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T
    Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity on chromosome 22q in gastrointestinal stromal tumors (GISTs): a study on 50 cases.
    Lasota J; Wozniak A; Kopczynski J; Dansonka-Mieszkowska A; Wasag B; Mitsuhashi T; Sarlomo-Rikala M; Lee JR; Schneider-Stock R; Stachura J; Limon J; Miettinen M
    Lab Invest; 2005 Feb; 85(2):237-47. PubMed ID: 15580284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygosity loss at 22q and lack of INI1 gene mutation in gastrointestinal stromal tumor.
    Yamamoto H; Kohashi K; Tsuneyoshi M; Oda Y
    Pathobiology; 2011; 78(3):132-9. PubMed ID: 21613800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Putative chromosomal deletions on 9P, 9Q and 22Q occur preferentially in malignant gastrointestinal stromal tumors.
    Kim NG; Kim JJ; Ahn JY; Seong CM; Noh SH; Kim CB; Min JS; Kim H
    Int J Cancer; 2000 Mar; 85(5):633-8. PubMed ID: 10699941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of NF2 and NF1 tumor suppressor genes in distinctive gastrointestinal nerve sheath tumors traditionally diagnosed as benign schwannomas: s study of 20 cases.
    Lasota J; Wasag B; Dansonka-Mieszkowska A; Karcz D; Millward CL; Ryś J; Stachura J; Sobin LH; Miettinen M
    Lab Invest; 2003 Sep; 83(9):1361-71. PubMed ID: 13679444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
    Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
    Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.
    Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M
    Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.
    Ebert C; von Haken M; Meyer-Puttlitz B; Wiestler OD; Reifenberger G; Pietsch T; von Deimling A
    Am J Pathol; 1999 Aug; 155(2):627-32. PubMed ID: 10433955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of 14q and 22q in gastrointestinal stromal tumors (pacemaker cell tumors).
    Breiner JA; Meis-Kindblom J; Kindblom LG; McComb E; Liu J; Nelson M; Bridge JA
    Cancer Genet Cytogenet; 2000 Jul; 120(2):111-6. PubMed ID: 10942800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
    Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in c-kit gene exons 9 and 13 in gastrointestinal stromal tumors among Japanese.
    Sakurai S; Oguni S; Hironaka M; Fukayama M; Morinaga S; Saito K
    Jpn J Cancer Res; 2001 May; 92(5):494-8. PubMed ID: 11376557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic status of 1p, 14q, and 22q and NF2 gene mutations in sporadic schwannomas.
    Leone PE; Bello MJ; Mendiola M; Kusak ME; De Campos JM; Vaquero J; Sarasa JL; Pestana A; Rey JA
    Int J Mol Med; 1998 May; 1(5):889-92. PubMed ID: 9852312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas.
    De Vitis LR; Tedde A; Vitelli F; Ammannati F; Mennonna P; Bigozzi U; Montali E; Papi L
    Hum Genet; 1996 May; 97(5):632-7. PubMed ID: 8655144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas.
    Lomas J; Bello MJ; Arjona D; Alonso ME; Martinez-Glez V; Lopez-Marin I; Amiñoso C; de Campos JM; Isla A; Vaquero J; Rey JA
    Genes Chromosomes Cancer; 2005 Mar; 42(3):314-9. PubMed ID: 15609345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas.
    Papi L; De Vitis LR; Vitelli F; Ammannati F; Mennonna P; Montali E; Bigozzi U
    Hum Genet; 1995 Mar; 95(3):347-51. PubMed ID: 7868131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of loss of heterozygosity of the c-kit gene on prognosis after hepatectomy for metastatic liver gastrointestinal stromal tumors.
    Kikuchi H; Yamamoto M; Hiramatsu Y; Baba M; Ohta M; Kamiya K; Tanaka T; Suzuki S; Sugimura H; Kitagawa M; Kanai T; Kitayama Y; Kanda T; Nishikura K; Konno H
    Cancer Sci; 2007 Nov; 98(11):1734-9. PubMed ID: 17894554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region.
    Wozniak K; Piaskowski S; Gresner SM; Golanska E; Bieniek E; Bigoszewska K; Sikorska B; Szybka M; Kulczycka-Wojdala D; Zakrzewska M; Zawlik I; Papierz W; Stawski R; Jaskolski DJ; Och W; Sieruta M; Liberski PP; Rieske P
    Cancer Genet Cytogenet; 2008 May; 183(1):14-20. PubMed ID: 18474292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.